Fujifilm Holdings Corp said on Wednesday its Avigan drug reduced viral loads and symptoms of COVID-19 patients, paving the way for regulatory approval in Japan after months of delays
Coronavirus update: Maharashtra has 1,224,380 coronavirus cases, Andhra Pradesh 625,514, Tamil Nadu 547,337, Karnataka 526,876, and UP 358,893. Stay tuned for coronavirus India LIVE update
Pharmaceutical giants GlaxoSmithKline and Sanofi have agreed to provide Canada with up to 72 million doses of their potential COVID-19 vaccine as governments buy up supplies of unproven treatments in hopes of ensuring supplies of whatever works. On Tuesday, the companies reiterated their commitment to make the vaccine affordable and available globally. Both companies have significant R&D and manufacturing capability worldwide and are already working hard to scale up production, Roger Conner, president of GSK's vaccine unit, said in a statement. This announcement from the Government of Canada supports our ongoing efforts. The agreement with Canada follows earlier deals with the US, European Union and UK governments.
The US logged 36,695 new cases on Sunday, Johns Hopkins reported.
Russia registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, in August.
With the global vaccine race hotting up, and dozens of candidates being tested on humans, backers of Russia's 'Sputnik-V' shot see liability as a key battleground as they aim to capture market share
It said people with a history or laboratory evidence of prior novel coronavirus infection should be allowed to participate in trials if they did not have acute COVID-19 or other acute infectious illne
While 88,935 people have died in India so far, the country has managed to keep the fatality rate at less than two per cent
Can't let the guard down for next 2-3 months against Covid, says V K Paul of NITI Aayog; ICMR chief sas 50% vaccine efficacy acceptable in case of respiratory viruses
Business Standard brings you the top headlines of the day
The vaccine is being developed by China's CanSino Biologics and Pakistan is among the seven countries which will carry out the phase-III trials
Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally rather than via an injection
A price between 5 and 15 euros a dose "is a reasonable price for a vaccine," Sue Middleton, President of the Executive Board, of Vaccines Europe told a hearing in the EU Parliament
The trials are part of a deal between the Russian Direct Investment Fund and Dr Reddy's.
Kendriya Vidyalayas announce rules for partial reopening, Scepticism over India's low fatality rate, Ghost of Bhopal gas tragedy amid Covid--news on how the country is dealing with the pandemic
Seven states account for 65.5 per cent of the total confirmed Covid-19 cases and 77 per cent of the total deaths
Vaccines must be authorised by EMA before they can be used in the European Union. No Covid-19 vaccine has been authorised in Europe
Hong Kong Disneyland opens this week, US colleges become Covid reservoirs, UK lockdown may knock 2% off GDP, and other pandemic-related news across the globe
Telangana recorded 2,166 new Covid-19 cases and 10 related deaths, pushing the tally of positive cases to 174,000
Coronavirus update: Maharashtra has 1,208,642 coronavirus cases, Andhra Pradesh 625,514, Tamil Nadu 541,993, Karnataka 519537, and UP 354,275. Stay tuned for coronavirus India LIVE update